Diagnostic TH mRNA levels and CTC counts are typically higher in patients with more advanced metastatic disease [185,204,206,212] and in patients with high-risk disease [206,212], as observed in other solid malignancies [166]. This evidence concerns the gene TH and metastatic neoplasm.